Atlas Trials

Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC)

Clinical trial NCT04410887 · UNKNOWN

Trial details

NCT number
NCT04410887
Sponsor
Ruijin Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Stomach CancerGastric Cancer
Start date
2020-12-01
Primary completion
2021-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.